Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Motolese

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cardiologia (Rome, Italy)|January 1, 1988
[Personalized therapy of arterial hypertension: problems of clinical implementation]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1986
[Continuous monitoring, by invasive and non-invasive approach, of arterial pressure in clinical cardiovascular pharmacology]M Motolese
Bollettino Chimico Farmaceutico|June 1, 1970
[Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1978
[Beta-blockaders and cardiovascular therapy: facts and theories. Part I. Introduction, characterization; therapeutic indications: arterial hypertension]M Motolese
Cardiologia (Rome, Italy)|January 1, 1989
[Biostatistic methodology in research: a necessity or cosmetic?]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1978
[Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions]M Motolese
Giornale Italiano Di Cardiologia|August 1, 1990
[Anticoagulants and antiaggregants in ischemic heart disease]M Motolese
Giornale Italiano Di Cardiologia|June 1, 1985
[Methodologic aspects of clinical research]M Motolese
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1985
Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blockerR Buoninconti, M Motolese
European Heart Journal|June 1, 1981
Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a reviewA Reale, M Motolese
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cardiologia (Rome, Italy)|January 1, 1988
[Personalized therapy of arterial hypertension: problems of clinical implementation]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1986
[Continuous monitoring, by invasive and non-invasive approach, of arterial pressure in clinical cardiovascular pharmacology]M Motolese
Bollettino Chimico Farmaceutico|June 1, 1970
[Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1978
[Beta-blockaders and cardiovascular therapy: facts and theories. Part I. Introduction, characterization; therapeutic indications: arterial hypertension]M Motolese
Cardiologia (Rome, Italy)|January 1, 1989
[Biostatistic methodology in research: a necessity or cosmetic?]M Motolese
Giornale Italiano Di Cardiologia|January 1, 1978
[Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions]M Motolese
Giornale Italiano Di Cardiologia|August 1, 1990
[Anticoagulants and antiaggregants in ischemic heart disease]M Motolese
Giornale Italiano Di Cardiologia|June 1, 1985
[Methodologic aspects of clinical research]M Motolese
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1985
Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blockerR Buoninconti, M Motolese
European Heart Journal|June 1, 1981
Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a reviewA Reale, M Motolese
Pageof 8